Price Alert

Aardvark Therapeutics Inc... (AARD)

NASDAQ: AARD · Real-Time Price · USD

9.55

-0.12 (-1.24%)

At close: Aug 21, 2025, 11:56 AM

Aardvark Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Net Income	-36.64M	-27.72M	-20.59M	-13.85M	-11.78M	-6.33M	-4.15M	-2.11M
Depreciation & Amortization	-649K	19K	16K	162K	101K	53K	51K	26K
Stock-Based Compensation	1.19M	605K	439K	335K	262K	208K	141K	72K
Other Working Capital	-2.9M	-2.36M	775K	915K	167K	-372K	-498K	-260K
Other Non-Cash Items	4.83M	276K	473K	385K	1.04M	1.08M	839K	742K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.64M	-465K	1.57M	1.45M	1.23M	59K	378K	-316K
Operating Cash Flow	-32.91M	-27.29M	-18.09M	-11.52M	-9.15M	-4.93M	-2.74M	-1.58M
Capital Expenditures	-102K	-104K	-109K	-103K	-98K	-5K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-124.65M	-124.65M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	21.53M	12.03M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-11.89M	-11.89M	-11.89M	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-115.11M	-124.62M	-12M	-103K	-98K	-5K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.18M	81.83M	81.83M	83M	82.94M	n/a	n/a	n/a
Financial Cash Flow	87.85M	170.87M	81.99M	83M	82.94M	n/a	n/a	n/a
Net Cash Flow	-60.17M	18.96M	51.91M	71.39M	73.7M	-4.94M	-2.74M	-1.58M
Free Cash Flow	-33.02M	-27.39M	-18.2M	-11.62M	-9.24M	-4.94M	-2.74M	-1.58M